marketing-medtech

**Founder:** Émilie Théry-Merland — Présidente (SAS) — médecin généraliste; co-dirigeant: Guillaume Michaux, Directeur Général (infirmier / gérant du Pôle de Santé de Taissy)
**Background:** clinician | verified: True — Both founders are confirmed real, practicing healthcare clinicians, supporting the "clinician" claim. Émilie Théry-Merland (Présidente) is a médecin généraliste (general practitioner) registered in the official French government health directory (sante.fr) with RPPS number 10100974764, sector 1, practicing at 2 Rue Gutenberg, 51500 Taissy. Guillaume Michaux (Directeur Général) is an infirmier (nurse / IDEL) at the same 2 Rue Gutenberg, Taissy address (cabinet SCP Genson Sabbioni Michaux), listed in the official Assurance Maladie (Ameli) directory and on Doctolib. The address (2 Rue Gutenberg, Taissy) matches the company name GUTENBERG SANTE IA DEVELOPPEMENT and the Pôle de Santé / Centre Gutenberg Santé de Taissy.
**Stage / fundraise:** Pre-seed / very early. SAS incorporated 2025-08-01 (~10 months old as of June 2026), NAF 62.01Z (computer programming). It is the software/IA spin-out of an established physician group (Centre Gutenberg Santé / Pôle de Santé de Taissy). First product (Pastéo) went into internal use 2026-05-21. / No fundraising confirmed via public sources. No press, grant, or BPI/round announcement found for the entity. Search of healthtech fundraising indexes returned only unrelated companies (e.g., "Gutenberg Technology", an edtech publisher). Likely self-funded by the physician group; build-capacity need rather than team-staffing.
**Regulatory trigger:** Pastéo is an AI medical-assistance tool used by physicians; the public page stresses it "supports practitioners without replacing their decision" and patient opt-out + data confidentiality (GDPR/health-data posture). If Pastéo moves from internal decision-support toward any diagnostic/treatment claim or external distribution, it falls under EU MDR SaMD scope and IEC 62304 software-lifecycle requirements. No CE marking or SaMD classification is publicly claimed today — an MDR/IEC 62304 path is a latent, not yet triggered, milestone.
**Email:** contact@sante-taissy.fr (confidence medium) — contact@sante-taissy.fr is the published organizational contact email of the Centre Gutenberg Santé (shown on sante-taissy.fr and used in their LinkedIn recruiting posts). It is a real, published address — but it is the physician group's general inbox, not a confirmed personal address for Émilie Théry-Merland or the IA Développement entity (no dedicated domain found for the SAS). Hence medium, not high.
**LinkedIn:** Guillaume Michaux (DG): https://fr.linkedin.com/in/guillaume-michaux-779695154 — no public LinkedIn confirmed for Émilie Théry-Merland. **Website:** https://www.sante-taissy.fr/
**Score:** 9 -> Tier B
**Hook:** You just rolled out Pastéo to your physicians (21 May) and spun off a dedicated software company (Gutenberg Santé IA Développement, NAF 62.01Z) — but it's clinician-led with the AI built by an outside consultancy. OmDev gives you a senior dev team plus a dedicated CTO at a fixed monthly price ~3x cheaper than hiring that team in-house, and you own all the code. The kicker for medtech: our build pipeline produces compliance evidence (SOUP register signed every build, requirements-to-code-to-test traceability) that feeds an IEC 62304/MDR file — so the day Pastéo needs to go from internal assistant to a real SaMD, the dossier is already there.

---

## Founder & background
**Émilie Théry-Merland** — Présidente of the SAS, a practicing **médecin généraliste** at 2 Rue Gutenberg, Taissy (same address as the company) ([Doctolib](https://www.doctolib.fr/medecin-generaliste/taissy/emilie-thery-merland), [Ameli](https://annuairesante.ameli.fr/professionnels-de-sante/fiche-detaillee-thery-merland-emilie-BbM1kjI5MDu0)).
Co-dirigeant **Guillaume Michaux** (Directeur Général) is an **infirmier** and gérant of the related Pôle/SISA entities ([Pappers](https://www.pappers.fr/dirigeant/guillaume_michaux_1976-02)).
Leadership is fully **clinician / healthcare-operations** — no tech, finance, or insurance background found ([RNE](https://recherche-entreprises.api.gouv.fr/search?q=989954771)).
**Why OmDev fits:** non-technical clinical founders building software is exactly where a dedicated CTO + senior team de-risks the build.

## Funding & momentum
SAS **incorporated 2025-08-01** (~10 months old), NAF **62.01Z** (software dev), Taissy ([RNE](https://recherche-entreprises.api.gouv.fr/search?q=989954771)).
It is the **IA software arm spun out of an established physician group** (Centre Gutenberg Santé / Pôle de Santé de Taissy).
**No fundraising confirmed** — no round, grant, or press found; healthtech-funding searches surfaced only unrelated companies.
**Why OmDev fits:** fixed monthly price ~3x cheaper than building an in-house team — ideal for a self-funded group that needs build capacity, not headcount.

## Product & regulatory
**Pastéo** — an "IA d'assistance médicale" co-built with consultancy **Equancy**, deployed to group physicians from **21 May 2026**; framed as decision-support with strict data confidentiality and patient opt-out ([sante-taissy.fr](https://www.sante-taissy.fr/)).
**No CE marking / SaMD classification claimed today** — currently internal decision-support.
If Pastéo adds diagnostic/treatment claims or external distribution, it enters **EU MDR SaMD** scope and **IEC 62304** software-lifecycle territory — a latent, not-yet-triggered milestone.
**Why OmDev fits:** our pipeline emits the compliance evidence (signed SOUP register, requirements→code→test traceability) that pre-loads an IEC 62304/MDR file before that milestone hits.

## Pain & buying signals
**No CTO / no in-house dev team** evidence; the AI is built by an **external agency (Equancy)** — classic agency dependence ([sante-taissy.fr](https://www.sante-taissy.fr/)).
Creating a **dedicated software SAS** signals intent to build/own more, but leadership has zero engineering capacity.
Very early + clinician-led + agency-built + a possible MDR future = a team that will need both an engineering function and a compliance backbone.
**Why OmDev fits:** OmDev drops in a senior team + dedicated CTO + a compliance engine, client owns the code — the fastest path from "consultancy-built pilot" to an owned, audit-ready medtech product.

---
**Sources:** https://recherche-entreprises.api.gouv.fr/search?q=989954771 · https://www.sante-taissy.fr/ · https://www.doctolib.fr/medecin-generaliste/taissy/emilie-thery-merland · https://annuairesante.ameli.fr/professionnels-de-sante/fiche-detaillee-thery-merland-emilie-BbM1kjI5MDu0 · https://www.pappers.fr/dirigeant/guillaume_michaux_1976-02 · https://www.pappers.fr/entreprise/sisa-du-centre-gutenberg-sante-835328295 · https://fr.linkedin.com/posts/guillaume-michaux-779695154_le-centre-gutenberg-sant%C3%A9-de-taissy-recrute-activity-7186690673813639169-a3Ah